Related content

Gait variability in Parkinson’s disease: influence of walking speed and dopaminergic treatment

By Bryant Mon S   Rintala Diana H   Hou Jyhgong G   Charness Ann L   Fernandez Angel L   Collins Robert L   Baker Jeff   Lai Eugene C   Protas Elizabeth J  

Neurological Research, Vol. 33, Iss. 9, 2011-11 ,pp. : 959-964

Maney Publishing

Access to resources Recommend Favorite

Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment

By Blandini F.   Cosentino M.   Mangiagalli A.   Marino F.   Samuele A.   Rasini E.   Fancellu R.   Tassorelli C.   Pacchetti C.   Martignoni E.   Riboldazzi G.   Calandrella D.   Lecchini S.   Frigo G.   Nappi G.  

Journal of Neural Transmission, Vol. 111, Iss. 8, 2004-08 ,pp. : 1017-1030

Springer Publishing Company

Access to resources Recommend Favorite

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease

By Bohnen Nicolaas   Gedela Satyanarayana   Kuwabara Hiroto   Constantine Gregory   Mathis Chester   Studenski Stephanie   Moore Robert  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 84-90

Springer Publishing Company

Access to resources Recommend Favorite

Reactive Macrophages Increase Oxidative Stress and Alpha-Synuclein Nitration During Death of Dopaminergic Neuronal Cells in Co-Culture: Relevance to Parkinson’s Disease

By Shavali Shaik   Combs Colin   Ebadi Manuchair  

Neurochemical Research, Vol. 31, Iss. 1, 2006-01 ,pp. : 85-94

Springer Publishing Company

Access to resources Recommend Favorite

Parkinson’s disease: clinical manifestations and treatment

By Dawson Ted M.  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 263-269

Informa Healthcare

Access to resources Recommend Favorite